{"id":19887,"date":"2023-09-11T11:35:06","date_gmt":"2023-09-11T09:35:06","guid":{"rendered":"https:\/\/ggba.swiss\/haya-therapeutics-triumphs-at-the-13th-top-100-swiss-startup-award\/"},"modified":"2023-09-11T11:39:24","modified_gmt":"2023-09-11T09:39:24","slug":"haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/","title":{"rendered":"HAYA Therapeutics triomphe lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award"},"content":{"rendered":"\n

Organis\u00e9e au Startup Space \u00e0 Schlieren et orchestr\u00e9e par Venturelab en collaboration avec Credit Suisse et Swiss Venture Club, la 13e \u00e9dition du TOP 100 Swiss Startup Award<\/a> a mis en avant la d\u00e9termination in\u00e9branlable de la Suisse \u00e0 encourager l’innovation et l’entrepreneuriat. L’\u00e9dition de cette ann\u00e9e a honor\u00e9 des entreprises de divers secteurs – biotechnologie, foodtech et fintech, pour n’en nommer que quelques-uns, refl\u00e9tant la nature multifacette du paysage des start-ups en Suisse<\/a>.<\/p>\n\n\n\n

Au premier plan de cette c\u00e9l\u00e9bration se trouvait une start-up de Suisse occidentale, HAYA Therapeutics<\/a>. Arrivant en premi\u00e8re position, HAYA Therapeutics, bas\u00e9e \u00e0 Epalinges, est une entreprise de biotechnologie sp\u00e9cialis\u00e9e dans les m\u00e9dicaments de pr\u00e9cision, avec son candidat phare ciblant la fibrose cardiaque actuellement en essais pr\u00e9cliniques. Fond\u00e9e par Samir Ounzain et Daniel Blessing en 2019, l’entreprise est un bel exemple du pouvoir d’innovation \u00e9manant de la r\u00e9gion de la Health Valley<\/a>. Il est \u00e0 noter que HAYA avait obtenu la huiti\u00e8me place dans le classement de 2022<\/a>, marquant une ascension remarquable \u00e0 premi\u00e8re place cette ann\u00e9e.<\/p>\n\n\n\n

Au cours de leur histoire, qui dure depuis plus d’une d\u00e9cennie, les prix Startup Award ont mis en lumi\u00e8re plus de 553 start-ups high-tech, cr\u00e9ant un impressionnant total de 17\u2019955 emplois et attirant des investissements \u00e0 hauteur de CHF 12,7 milliards.<\/p>\n\n\n\n

Bien que HAYA Therapeutics ait \u00e9t\u00e9 sous les projecteurs avec sa premi\u00e8re place, l’\u00e9v\u00e9nement a \u00e9galement \u00e9t\u00e9 une r\u00e9flexion plus large sur la puissance du monde des start-ups suisses. La diversit\u00e9 des secteurs repr\u00e9sent\u00e9s, l’\u00e9mergence de l’intelligence artificielle et la mont\u00e9e des start-ups cleantech sont des indicateurs clairs de l’adaptabilit\u00e9 de la Suisse et de son approche prospective de l’innovation.<\/p>\n\n\n\n

Stefan Steiner, directeur du programme TOP 100, a encapsul\u00e9 l’essence de l’\u00e9v\u00e9nement en d\u00e9clarant : \u00ab Le classement refl\u00e8te la force de l’\u00e9cosyst\u00e8me des start-ups suisses… Les start-ups demeurent de v\u00e9ritables moteurs de l’innovation. \u00bb Avec 41 nouveaux nomin\u00e9s pr\u00e9sent\u00e9s cette ann\u00e9e, le paysage entrepreneurial suisse continue d’\u00e9voluer, offrant au monde un aper\u00e7u de l’avenir des affaires et de la technologie.<\/p>\n\n\n\n

Une recherche mondiale des prochaines grandes licornes suisses<\/h4>\n\n\n\n

Des \u00ab licornes \u00bb reconnues telles que Climeworks, GetYourGuide, MindMaze et Sophia Genetics trouvent toutes leurs origines dans une reconnaissance pr\u00e9coce au classement TOP 100 Swiss Startups, illustrant l’influence profonde de ce sommet dans l’identification et le soutien des futurs leaders du march\u00e9 mondial.<\/p>\n\n\n\n

La r\u00e9putation d’innovation de la Suisse est encore amplifi\u00e9e par le terme \u00ab\u00a0Soonicorns\u00a0\u00bb, qui d\u00e9signe les start-ups sur le point d’atteindre le statut de licorne – une valorisation de plus de USD 1 milliard. Ces entreprises en plein essor sont le point central du Investor Summit<\/a>. Avec la participation d’\u00e9minents d\u2019investisseurs en capital-risque, \u00ab\u00a0super angels\u00a0\u00bb, VCs et repr\u00e9sentants de bureaux de famille fortun\u00e9s venant d’Europe, d’Am\u00e9rique et d’Asie, l’\u00e9v\u00e9nement cr\u00e9e une plateforme sans pr\u00e9c\u00e9dent pour les start-ups suisses prometteuses afin d’obtenir des investissements et du mentorat.<\/p>\n","protected":false},"excerpt":{"rendered":"

La sc\u00e8ne florissante des start-ups en Suisse occidentale a connu une nouvelle ann\u00e9e remarquable d’innovation et de croissance, Haya Therapeutics remportant la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.<\/p>\n","protected":false},"author":6,"featured_media":19883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1148,1140,1142],"class_list":["post-19887","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-financing-fr-2","tag-oncology-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"\nHAYA Therapeutics triomphe au TOP 100 Swiss Startup Award<\/title>\n<meta name=\"description\" content=\"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HAYA Therapeutics triomphe au TOP 100 Swiss Startup Award\" \/>\n<meta property=\"og:description\" content=\"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-11T09:35:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-11T09:39:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"HAYA Therapeutics triomphe lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award\",\"datePublished\":\"2023-09-11T09:35:06+00:00\",\"dateModified\":\"2023-09-11T09:39:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\"},\"wordCount\":546,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Financing\",\"Oncology\",\"R&D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\",\"name\":\"HAYA Therapeutics triomphe au TOP 100 Swiss Startup Award\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg\",\"datePublished\":\"2023-09-11T09:35:06+00:00\",\"dateModified\":\"2023-09-11T09:39:24+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"La start-up biotechnologique vaudoise, class\u00e9e premi\u00e8re au TOP 100 Swiss Startup Award 2023, exploite le g\u00e9nome obscur pour \u00e9laborer des th\u00e9rapies RNA pr\u00e9cises pour la modification des \u00e9tats cellulaires des maladies.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HAYA Therapeutics triomphe lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HAYA Therapeutics triomphe au TOP 100 Swiss Startup Award","description":"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/","og_locale":"fr_FR","og_type":"article","og_title":"HAYA Therapeutics triomphe au TOP 100 Swiss Startup Award","og_description":"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.","og_url":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-09-11T09:35:06+00:00","article_modified_time":"2023-09-11T09:39:24+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"HAYA Therapeutics triomphe lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award","datePublished":"2023-09-11T09:35:06+00:00","dateModified":"2023-09-11T09:39:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/"},"wordCount":546,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg","keywords":["Biotech","Financing","Oncology","R&D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/","url":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/","name":"HAYA Therapeutics triomphe au TOP 100 Swiss Startup Award","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg","datePublished":"2023-09-11T09:35:06+00:00","dateModified":"2023-09-11T09:39:24+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La biotech vaudoise Haya Therapeutics a remport\u00e9 la premi\u00e8re place lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Haya-Therapeutics-Top-100-1180x811-1.jpg","width":1180,"height":811,"caption":"La start-up biotechnologique vaudoise, class\u00e9e premi\u00e8re au TOP 100 Swiss Startup Award 2023, exploite le g\u00e9nome obscur pour \u00e9laborer des th\u00e9rapies RNA pr\u00e9cises pour la modification des \u00e9tats cellulaires des maladies."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/haya-therapeutics-triomphe-lors-de-la-13e-edition-du-top-100-swiss-startup-award\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"HAYA Therapeutics triomphe lors de la 13e \u00e9dition du TOP 100 Swiss Startup Award"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=19887"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19887\/revisions"}],"predecessor-version":[{"id":19889,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19887\/revisions\/19889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/19883"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=19887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=19887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=19887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}